Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

93 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Off-Treatment Form NCT00058149

- 03-06-15 - 1 Formulier, 4 Itemgroepen, 21 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, Vital Status, Comments, CCRR MODULE
Off-Treatment Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A65D62C3-9044-4286-E034-0003BA0B1A09

Non-Protocol Therapy Form NCT00058149

- 03-06-15 - 1 Formulier, 4 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, Non-Protocol Therapy, Comments, CCRR MODULE
Non-Protocol Therapy Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A65D54AA-6F5F-4282-E034-0003BA0B1A09

Adverse Event Form NCT00058149

- 03-06-15 - 1 Formulier, 4 Itemgroepen, 18 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, Adverse event, Comments, CCRR MODULE
Adverse Event Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6276505-5438-3D62-E034-0003BA0B1A09

Nontarget Lesions Supplemental Form NCT00057876

- 03-06-15 - 1 Formulier, 4 Itemgroepen, 20 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, NONTARGET LESIONS:, Comments, CCRR MODULE
Nontarget Lesions Supplemental Form NCT00057876 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6238F51-F0B5-3C1D-E034-0003BA0B1A09

Treatment Form NCT00058149

- 03-06-15 - 1 Formulier, 8 Itemgroepen, 24 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, Vital Status, Arm A, Arm B, Arm C, Non-Protocol Therapy, Comments, CCRR MODULE
Treatment Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A65C8791-5AF1-42A8-E034-0003BA0B1A09

Supplemental Form

- 02-06-15 - 1 Formulier, 7 Itemgroepen, 22 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, Data amendment, CEA, CA19-19, Thrombosis / Embolism, Comments, CCRR MODULE
Supplemental Form A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A65C81E5-2ACA-42A6-E034-0003BA0B1A09

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

- 27-02-20 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas; ODM derived from: https://clinicaltrials.gov/show/NCT01985958

BRIEF PAIN INVENTORY (SHORT FORM) NCT00075686

- 03-07-15 - 1 Formulier, 2 Itemgroepen, 23 Data-elementen, 1 Taal
Itemgroepen: SWOG clinical trial administrative data, Quality of life assessment
BRIEF PAIN INVENTORY (SHORT FORM) NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A66323E9-44F6-48CB-E034-0003BA0B1A09

NCT00075686 COVERSHEET FOR PATIENT-COMPLETE QUESTIONNAIRES: S0205

- 03-07-15 - 1 Formulier, 3 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Header, Miscellaneous Patient Information, CCRR MODULE
NCT00075686 COVERSHEET FOR PATIENT-COMPLETE QUESTIONNAIRES: S0205 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B186CE8D-98A1-0591-E034-0003BA12F5E7

NCT00075686 COVER SHEET FOR PATIENT-COMPLETE QUESTIONNAIRES: S0205 - NCT00075686 COVERSHEET FOR PATIENT-COMPLETE QUESTIONNAIRES: S0205

- 03-07-15 - 1 Formulier, 4 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Header, Miscellaneous Patient Information, CCRR MODULE, CCRR MODULE
NCT00075686 COVER SHEET FOR PATIENT-COMPLETE QUESTIONNAIRES: S0205 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6631050-8DCA-48C7-E034-0003BA0B1A09

S0205 LASA QUALITY OF LIFE QUESTIONNAIRE NCT00075686

- 03-07-15 - 1 Formulier, 4 Itemgroepen, 16 Data-elementen, 1 Taal
Itemgroepen: SWOG clinical trial administrative data, Quality of life assessment, CCRR MODULE, CCRR MODULE
S0205 LASA QUALITY OF LIFE QUESTIONNAIRE NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A66316F3-7D6E-48C9-E034-0003BA0B1A09

CALGB: QOL ASSESSMENT SUMMARY FORM [803030] NCT00088894

- 29-06-15 - 1 Formulier, 4 Itemgroepen, 22 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Method of Evaluation, Footer module
CALGB: QOL ASSESSMENT SUMMARY FORM [803030] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D5EBCEB3-8BEC-0795-E034-0003BA12F5E7

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial